Concepedia

Yue Tan

YT

8

Publications

591

Citations

8

H-Index

2020

Active since

Affiliations

Institute of Hematology & Blood Diseases Hospital(Current)

Chinese Academy of Medical Sciences & Peking Union Medical College

Beijing Tongren Hospital

Union Hospital

Fujian Medical University

Yue Tan is an author at Institute of Hematology & Blood Diseases Hospital specializing in immunology, immunotherapy, and medicine.

ORCID

Top concepts

Publications per year

2020–2024

8

Publications

8

Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial

Jing Pan, Yue Tan, Guoling Wang et al. · Journal of Clinical Oncology · 2021 · 280 citations

Ruxolitinib mitigates steroid‐refractory CRS during CAR T therapy

Jing Pan, Biping Deng, Zhuojun Ling et al. · Journal of Cellular and Molecular Medicine · 2020 · 83 citations · Full text

, , +16

Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemia

Yue Tan, Lingling Shan, Liping Zhao et al. · Journal of Hematology & Oncology · 2023 · 75 citations · Full text

Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study

Jing Pan, Kaiting Tang, Yuechen Luo et al. · The Lancet Oncology · 2023 · 53 citations

, , +9

Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial

Jing Pan, Yue Tan, Lingling Shan et al. · Nature Medicine · 2024 · 36 citations

, , +9

Rows per page

1–5 of 8